Allen James Bailey, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alcoholism | 6 | 2023 | 1906 | 1.610 |
Why?
|
| Alcohol-Related Disorders | 2 | 2023 | 234 | 1.440 |
Why?
|
| Collagen | 13 | 2009 | 2688 | 1.330 |
Why?
|
| Substance-Related Disorders | 8 | 2023 | 4257 | 1.210 |
Why?
|
| Impulsive Behavior | 2 | 2022 | 316 | 0.850 |
Why?
|
| Psychopathology | 2 | 2021 | 409 | 0.770 |
Why?
|
| Osteoarthritis | 5 | 2007 | 1036 | 0.730 |
Why?
|
| Reward | 3 | 2021 | 940 | 0.620 |
Why?
|
| Alcohol Drinking | 6 | 2023 | 3966 | 0.570 |
Why?
|
| Memory, Short-Term | 2 | 2023 | 977 | 0.530 |
Why?
|
| Behavior, Addictive | 1 | 2021 | 462 | 0.530 |
Why?
|
| Bone and Bones | 5 | 2007 | 2576 | 0.500 |
Why?
|
| Intelligence | 1 | 2019 | 920 | 0.480 |
Why?
|
| Ligaments, Articular | 2 | 2006 | 299 | 0.420 |
Why?
|
| Anterior Cruciate Ligament | 2 | 2005 | 415 | 0.400 |
Why?
|
| Borderline Personality Disorder | 1 | 2019 | 736 | 0.400 |
Why?
|
| Decision Making | 2 | 2022 | 3888 | 0.370 |
Why?
|
| Guinea Pigs | 6 | 2008 | 1386 | 0.350 |
Why?
|
| Schizotypal Personality Disorder | 2 | 2021 | 288 | 0.340 |
Why?
|
| Antisocial Personality Disorder | 2 | 2020 | 228 | 0.330 |
Why?
|
| Fibrillar Collagens | 1 | 2008 | 41 | 0.320 |
Why?
|
| Oligopeptides | 2 | 2004 | 1189 | 0.310 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 2838 | 0.310 |
Why?
|
| Hallucinogens | 2 | 2022 | 180 | 0.310 |
Why?
|
| Depressive Disorder | 1 | 2020 | 3747 | 0.290 |
Why?
|
| Collagen Type I | 3 | 2005 | 592 | 0.270 |
Why?
|
| Leg Bones | 1 | 2005 | 19 | 0.260 |
Why?
|
| Stifle | 1 | 2004 | 28 | 0.250 |
Why?
|
| Psychotic Disorders | 3 | 2024 | 3046 | 0.240 |
Why?
|
| Calorimetry, Differential Scanning | 4 | 2004 | 94 | 0.240 |
Why?
|
| Protein Denaturation | 4 | 2004 | 237 | 0.230 |
Why?
|
| Malondialdehyde | 1 | 2003 | 105 | 0.230 |
Why?
|
| Arthritis, Experimental | 1 | 2006 | 291 | 0.230 |
Why?
|
| Tendons | 2 | 2004 | 548 | 0.220 |
Why?
|
| Serum Albumin, Bovine | 1 | 2003 | 324 | 0.220 |
Why?
|
| Hindlimb | 1 | 2005 | 504 | 0.220 |
Why?
|
| Tranquilizing Agents | 1 | 2022 | 59 | 0.220 |
Why?
|
| Histidine | 1 | 2003 | 313 | 0.220 |
Why?
|
| Dogs | 2 | 2005 | 3912 | 0.220 |
Why?
|
| Osteoblasts | 3 | 2007 | 1166 | 0.200 |
Why?
|
| Delusions | 1 | 2023 | 300 | 0.200 |
Why?
|
| Temperature | 2 | 2004 | 2204 | 0.200 |
Why?
|
| Biomimetic Materials | 1 | 2003 | 179 | 0.200 |
Why?
|
| Young Adult | 9 | 2022 | 56429 | 0.190 |
Why?
|
| Protein Structure, Quaternary | 1 | 2002 | 436 | 0.190 |
Why?
|
| Procollagen | 3 | 2005 | 185 | 0.180 |
Why?
|
| Mental Disorders | 1 | 2020 | 6598 | 0.180 |
Why?
|
| Bone Remodeling | 1 | 2004 | 575 | 0.180 |
Why?
|
| Cartilage | 1 | 2004 | 818 | 0.180 |
Why?
|
| Femur | 1 | 2005 | 1297 | 0.170 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2009 | 1572 | 0.170 |
Why?
|
| Syndrome | 2 | 2022 | 3252 | 0.160 |
Why?
|
| Matrix Metalloproteinase 2 | 3 | 2005 | 472 | 0.160 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2022 | 1953 | 0.160 |
Why?
|
| Marijuana Abuse | 1 | 2022 | 403 | 0.160 |
Why?
|
| Analgesics, Opioid | 4 | 2023 | 3677 | 0.150 |
Why?
|
| Cross-Linking Reagents | 3 | 2005 | 694 | 0.150 |
Why?
|
| Hydrolysis | 2 | 2009 | 682 | 0.150 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2022 | 632 | 0.150 |
Why?
|
| Factor Analysis, Statistical | 1 | 2019 | 977 | 0.140 |
Why?
|
| Heroin | 1 | 2016 | 117 | 0.140 |
Why?
|
| Knee Joint | 1 | 2005 | 1680 | 0.140 |
Why?
|
| Cannabis | 1 | 2022 | 440 | 0.130 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 2 | 2005 | 68 | 0.130 |
Why?
|
| Humans | 29 | 2024 | 744366 | 0.130 |
Why?
|
| Personality Disorders | 1 | 2019 | 713 | 0.130 |
Why?
|
| Osteoarthritis, Knee | 1 | 2005 | 1222 | 0.130 |
Why?
|
| Peptides | 2 | 2003 | 4410 | 0.120 |
Why?
|
| Paranoid Disorders | 2 | 2024 | 60 | 0.110 |
Why?
|
| Lysine | 3 | 2008 | 1007 | 0.110 |
Why?
|
| Arginine | 2 | 2008 | 944 | 0.100 |
Why?
|
| Adolescent | 5 | 2020 | 85779 | 0.100 |
Why?
|
| Glycosaminoglycans | 2 | 2005 | 624 | 0.100 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2005 | 638 | 0.100 |
Why?
|
| Central Nervous System Stimulants | 1 | 2019 | 1148 | 0.100 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2008 | 3759 | 0.090 |
Why?
|
| Male | 11 | 2020 | 350115 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2006 | 18034 | 0.080 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2009 | 220 | 0.080 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2009 | 306 | 0.080 |
Why?
|
| Anxiety Disorders | 1 | 2020 | 2690 | 0.080 |
Why?
|
| Borohydrides | 1 | 2008 | 32 | 0.080 |
Why?
|
| Buffers | 1 | 2008 | 147 | 0.080 |
Why?
|
| Hydroxyproline | 2 | 2004 | 116 | 0.080 |
Why?
|
| Female | 11 | 2020 | 380193 | 0.080 |
Why?
|
| Adult | 6 | 2023 | 214052 | 0.070 |
Why?
|
| Personality | 2 | 2021 | 552 | 0.070 |
Why?
|
| Animals | 13 | 2008 | 168768 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 15535 | 0.070 |
Why?
|
| Prevalence | 1 | 2023 | 15221 | 0.070 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 25039 | 0.070 |
Why?
|
| Glucose | 2 | 2009 | 4398 | 0.070 |
Why?
|
| Ethanol | 2 | 2023 | 1342 | 0.070 |
Why?
|
| Carbohydrates | 1 | 2008 | 394 | 0.070 |
Why?
|
| Cognition | 1 | 2023 | 6770 | 0.070 |
Why?
|
| Elastin | 2 | 2003 | 308 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2020 | 9145 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2008 | 2184 | 0.060 |
Why?
|
| Neuropsychological Tests | 1 | 2018 | 6994 | 0.060 |
Why?
|
| Chorionic Gonadotropin | 1 | 2007 | 476 | 0.060 |
Why?
|
| Glycosylation | 1 | 2008 | 1128 | 0.060 |
Why?
|
| Calorimetry | 1 | 2004 | 126 | 0.060 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2004 | 99 | 0.060 |
Why?
|
| Comorbidity | 1 | 2019 | 10388 | 0.060 |
Why?
|
| Luteinizing Hormone | 1 | 2007 | 869 | 0.060 |
Why?
|
| Rupture, Spontaneous | 1 | 2005 | 354 | 0.060 |
Why?
|
| Epiphyses | 1 | 2005 | 189 | 0.060 |
Why?
|
| Metalloproteases | 1 | 2004 | 62 | 0.060 |
Why?
|
| Thermodynamics | 1 | 2004 | 594 | 0.060 |
Why?
|
| Hydroxylysine | 1 | 2002 | 5 | 0.060 |
Why?
|
| Hydrogen Bonding | 1 | 2003 | 291 | 0.050 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2002 | 59 | 0.050 |
Why?
|
| X-Ray Diffraction | 1 | 2003 | 420 | 0.050 |
Why?
|
| Peptide Fragments | 2 | 2005 | 5096 | 0.050 |
Why?
|
| Collagen Type III | 1 | 2002 | 90 | 0.050 |
Why?
|
| Risk Factors | 2 | 2019 | 72296 | 0.050 |
Why?
|
| Tail | 1 | 2002 | 97 | 0.050 |
Why?
|
| Pyrroles | 1 | 2009 | 1146 | 0.050 |
Why?
|
| Skin | 2 | 2008 | 4372 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 1801 | 0.050 |
Why?
|
| Bone Density | 2 | 2006 | 3468 | 0.050 |
Why?
|
| Amino Acids | 1 | 2008 | 1737 | 0.050 |
Why?
|
| Opioid-Related Disorders | 1 | 2016 | 2064 | 0.050 |
Why?
|
| Twins | 1 | 2023 | 339 | 0.050 |
Why?
|
| Rats | 3 | 2008 | 24252 | 0.050 |
Why?
|
| Femur Head | 1 | 2004 | 301 | 0.050 |
Why?
|
| Schizophrenia | 1 | 2020 | 6882 | 0.050 |
Why?
|
| Diaphragm | 1 | 2002 | 349 | 0.050 |
Why?
|
| Protein Structure, Secondary | 1 | 2004 | 1247 | 0.050 |
Why?
|
| Prognosis | 1 | 2020 | 29060 | 0.040 |
Why?
|
| Avoidance Learning | 1 | 2020 | 233 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2002 | 1865 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2002 | 959 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2006 | 1782 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 2887 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2004 | 1356 | 0.040 |
Why?
|
| Water | 1 | 2004 | 1395 | 0.040 |
Why?
|
| Time Factors | 1 | 2020 | 40075 | 0.040 |
Why?
|
| Nucleus Accumbens | 1 | 2020 | 366 | 0.040 |
Why?
|
| Self Report | 2 | 2021 | 3553 | 0.040 |
Why?
|
| Joint Instability | 1 | 2006 | 792 | 0.040 |
Why?
|
| Cattle | 1 | 2003 | 3922 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 3873 | 0.040 |
Why?
|
| Personality Inventory | 1 | 2020 | 1030 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2002 | 1125 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2004 | 1741 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2003 | 2204 | 0.030 |
Why?
|
| Heroin Dependence | 1 | 2016 | 175 | 0.030 |
Why?
|
| United States | 1 | 2023 | 69872 | 0.030 |
Why?
|
| Kinetics | 1 | 2003 | 6476 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2003 | 4010 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2003 | 1736 | 0.030 |
Why?
|
| Hypnotics and Sedatives | 1 | 2022 | 1162 | 0.030 |
Why?
|
| Binding Sites | 1 | 2003 | 6111 | 0.030 |
Why?
|
| Psychometrics | 1 | 2024 | 3003 | 0.030 |
Why?
|
| Social Class | 1 | 2023 | 1997 | 0.030 |
Why?
|
| Gyrus Cinguli | 1 | 2020 | 1091 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 6621 | 0.030 |
Why?
|
| Radiography | 1 | 2005 | 7023 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2020 | 63107 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2003 | 5451 | 0.030 |
Why?
|
| Executive Function | 1 | 2020 | 1364 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 13814 | 0.020 |
Why?
|
| Motivation | 1 | 2020 | 1971 | 0.020 |
Why?
|
| Protein Binding | 1 | 2003 | 9384 | 0.020 |
Why?
|
| Prefrontal Cortex | 1 | 2020 | 2147 | 0.020 |
Why?
|
| Attention | 1 | 2020 | 2397 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 2003 | 2646 | 0.020 |
Why?
|
| Disease Progression | 1 | 2006 | 13286 | 0.020 |
Why?
|
| Receptors, LH | 1 | 2007 | 19 | 0.020 |
Why?
|
| Parents | 1 | 2020 | 3405 | 0.020 |
Why?
|
| Goserelin | 1 | 2007 | 129 | 0.020 |
Why?
|
| Calcitriol | 1 | 2007 | 297 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2003 | 5749 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2007 | 661 | 0.020 |
Why?
|
| Deamination | 1 | 2003 | 26 | 0.020 |
Why?
|
| Phenotype | 1 | 2002 | 16367 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2005 | 1157 | 0.010 |
Why?
|
| Desmosine | 1 | 2002 | 19 | 0.010 |
Why?
|
| Bone Resorption | 1 | 2007 | 723 | 0.010 |
Why?
|
| Cell Count | 1 | 2007 | 1856 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2007 | 1794 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2002 | 803 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 1581 | 0.010 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2007 | 1206 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2007 | 6313 | 0.010 |
Why?
|
| Mice | 2 | 2002 | 81201 | 0.010 |
Why?
|
| Homozygote | 1 | 2002 | 1787 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2002 | 57776 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 8300 | 0.010 |
Why?
|
| Middle Aged | 2 | 2016 | 213390 | 0.010 |
Why?
|
| Aorta | 1 | 2002 | 2062 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 35425 | 0.010 |
Why?
|
| Alleles | 1 | 2002 | 6933 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2002 | 9735 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 14723 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2007 | 11486 | 0.010 |
Why?
|
| Aged | 1 | 2002 | 163288 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 9274 | 0.000 |
Why?
|
| Lung | 1 | 2002 | 9857 | 0.000 |
Why?
|
| Mutation | 1 | 2002 | 29786 | 0.000 |
Why?
|